Financials( ₹ in Cr) | Infinium Pharmachem Ltd | Sun Pharmaceuticals Industries Ltd | Cipla Ltd | Dr Reddys Laboratories Ltd | Zydus Lifesciences Ltd |
---|---|---|---|---|---|
Price | 229.00 | 1,620.55 | 1,496.95 | 6,157.90 | 1,007.35 |
% Change | -1.29 | 1.02 | 2.30 | 1.88 | 0.77 |
Mcap ₹ Cr | 318.68 | 388,824.23 | 120,856.26 | 102,719.31 | 101,964.37 |
Revenue TTM ₹ Cr | 114.22 | 43,885.68 | 15,790.60 | 24,669.70 | 17,237.40 |
Net Profit TTM ₹ Cr | 9.82 | 8,560.84 | 2,513.47 | 4,507.30 | 1,997.30 |
PE TTM | 33.58 | 41.45 | 30.52 | 19.64 | 30.51 |
1 Year Return | 209.88 | 64.78 | 68.33 | 37.28 | 109.04 |
ROCE | 36.74 | 16.79 | 14.76 | 25.99 | 16.25 |
ROE | 55.06 | 16.46 | 10.66 | 21.21 | 14.05 |
Equity Capital: 22.56 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 29,068.81 | 33,709.58 |
LAST 3M | 68,518.10 | 30,558.15 |
LAST 6M | 130,081.93 | 64,349.19 |
LAST 12M | 189,941.35 | 208,211.24 |
Date | Action Type | Ratio |
---|---|---|
Sep 13, 2023 | Bonus | 1:1 |
Infinium Pharmachem Limited was originally incorporated as "Infinium Pharmachem Private Limited" on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted into Public Company and the name of Company was changed to "Infinium Pharmachem Limited" vide fresh Certificate of Incorporation dated August 12, 2022 by the RoC, Gujarat. Led by the Promoter, Sanjaykumar Viththalbhai Patel,in 2003, the Company established itself as a globally integrated & admired Pharmaceutical & Healthcare Company having manufacturing plant at Sojitra, Gujarat. The Company was incorporated with the objective of Manufacturing and supplying of Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It has penetrated the Pharmaceutical market with the CRAMS i.e. Contract Research & Manufacturing Services emphasizing on process optimization; developing / manufacturing the products specifically as per customer`s requirement and final application; customized packing / labelling; reliable supply of final product and focused to Iodine Chemistry. As of today, the Company`s manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc. Apart from these, it provides a range of Iodine derivatives in the market, with more than 200 intermediates and over 7 APIs. Later, in 2019, the Company formed a Joint Venture (JV) with Shanghai Witofly Chemical Co. Ltd., in the name of Shanghai Tajilin Industrial Co. Ltd., in the People`s Republic of China. It also formed a Subsidiary Company in the name of Infinium Green Energy Private Limited on June 06, 2022. The Company is proposing a public issue of issuing upto 18,75,000 equity shares through fresh issue.
AGM Date (Month) | : | Aug |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1000 |
BSE Code | : | 78690 |
NSE Code | : | INFINIUM |
Book Closure Date (Month) | : | Aug |
BSE Group | : | |
ISIN | : | INE0MRE01011 |
You can buy Infinium Pharmachem Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Infinium Pharmachem Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 03:31 PM the closing price of Infinium Pharmachem Ltd was ₹ 229.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 03:31 PM, the market cap of Infinium Pharmachem Ltd stood at ₹ 318.68.
The latest PE ratio of Infinium Pharmachem Ltd as of Mar 28, 2024 03:31 PM is 33.58
The latest PB ratio of Infinium Pharmachem Ltd as of Mar 28, 2024 03:31 PM is 0.15
The 52-week high of Infinium Pharmachem Ltd share price is ₹ 315.70 while the 52-week low is ₹ 70.75